News
Ouster (OUST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
23h
Zacks.com on MSNGEN or DUOL: Which Is the Better Value Stock Right Now?Investors interested in stocks from the Technology Services sector have probably already heard of Gen Digital (GEN) and Duolingo, Inc. (DUOL). But which of these two companies is the best option for ...
17h
Zacks Investment Research on MSNHumacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should KnowHumacyte, Inc. (HUMA) ended the recent trading session at $2.33, demonstrating a -3.72% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0 ...
17h
Zacks Investment Research on MSNHere's Why Moderna (MRNA) Fell More Than Broader MarketModerna (MRNA) ended the recent trading session at $31.25, demonstrating a -2.95% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.01%. Elsewhere, the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results